FDA: Risk of Opioids in Kids' Cough Medicines Outweighs Benefits

A federal advisory committee sent a strong message to the Food and Drug Administration on Monday, declaring nearly unanimously that the risks of using certain opioids in children's cough medications outweighs the benefits.